Search

Search Constraints

You searched for: Author/Creator Burandt, Eike

Search Results

1. 13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer. Issue 10 (20th August 2018)

2. 5q21 deletion is often heterogeneous in prostate cancer. Issue 8 (24th January 2019)

3. A shift from membranous and stromal syndecan‐1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer. Issue 12 (23rd September 2019)

4. Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas. (January 2022)

5. Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice. Issue 3 (5th December 2013)

8. Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10, 439 tumors. Issue 2 (7th November 2022)

9. Detection of stage I HPV-driven oropharyngeal cancer in asymptomatic individuals in the Hamburg City Health Study using HPV16 E6 serology – A proof-of-concept study. (November 2022)

10. Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16, 000 Tumors. (8th August 2022)